Serum immunogloblins might be useful predictors of immune‐related adverse events after immune checkpoint inhibitor usage in lung cancer

We herein report a 79‐year‐old woman who underwent surgery had recurred non‐small cell lung cancer and developed irAEs following ICI treatment. During ICI treatment, we conducted monthly measurements of the serum antibody levels in this patient, including those which were both tumor‐ (anti‐p53 antib...

Descripción completa

Detalles Bibliográficos
Autores principales: Yasuda, Manabu, Take, Nobuyuki, Shinohara, Shinji, Chikaishi, Yasuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2022
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9436670/
https://www.ncbi.nlm.nih.gov/pubmed/35869681
http://dx.doi.org/10.1111/1759-7714.14573

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9436670/
https://www.ncbi.nlm.nih.gov/pubmed/35869681
http://dx.doi.org/10.1111/1759-7714.14573

Ejemplares similares